ERVW-1 and myeloid sarcoma: Accordingly, HERV-W Env overexpression led to development of allergic encephalomyelitis in mice [11], while treatment with a monoclonal antibody against HERV-W Env rescued myelin expression [12], a phenomenon currently investigated as an innovative clinical approach for treating MS [13].